Is Teladoc Stock a Buy After a Huge Second Quarter?

Investors had high expectations for Teladoc Health (NYSE: TDOC) going into the company's second-quarter update on Wednesday. Shares have surged more than 150% year to date as investors bet that the telehealth specialist would benefit from mass adoption of virtual care during the COVID-19 pandemic.

Based on tech company's strong second-quarter results, it looks like investors were right about Teladoc's strong value proposition as a solution to minimize unnecessary physical interaction with patients and to help mitigate the spread of the coronavirus. The company's revenue growth rate more than doubled compared to the prior quarter and total virtual visits soared.

Here's a closer look at Teladoc Health's strong second-quarter results.

Continue reading

Source Fool.com